Infected Blood Compensation Scheme

(asked on 21st October 2026) - View Source

Question to the Cabinet Office:

To ask the Minister for the Cabinet Office, whether the Government will amend the Infected Blood Compensation Scheme regulations to enable the estates of deceased people treated with blood products for haemophilia before 1991 to receive compensation for hepatitis C infection where no positive test result or contemporaneous medical records are available; and when she expects a decision on this matter to be made.


Answered by
Mark Ferguson Portrait
Mark Ferguson
Parliamentary Secretary (Cabinet Office)
This question was answered on 16th November 2026

The Infected Blood Compensation Scheme compensates for infection and the impact of infection, and not pre-existing congenital conditions, including haemophilia or other bleeding disorders. Claims to the Scheme must be supported by evidence, which includes showing that the person claiming was likely to have been infected with a relevant infection, such as Hepatitis C. Where evidence is missing, IBCA will take into account all relevant information when coming to a decision. This might include the person’s treatment history.

While the Infected Blood Inquiry may have noted particular circumstances that are related to individuals with haemophilia who were infected with Hepatitis C, at no point does it suggest that such people should be treated differently in a compensation scheme, nor did it make further recommendations on this point in its Additional Report.

Reticulating Splines